(Q43035339)

English

Design and optimisation of orally active TLR7 agonists for the treatment of hepatitis C virus infection.

scientific article published on 16 March 2011

In more languages
default values for all languages
No label defined

No description defined

Statements

Design and optimisation of orally active TLR7 agonists for the treatment of hepatitis C virus infection (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit